Fulminant Diabetes in a Patient with Advanced Melanoma on Nivolumab

Fulminant Diabetes in a Patient with Advanced Melanoma on Nivolumab

Background. Anti-PD-1 agents were approved for advanced melanoma after the landmark trial Checkmate-037. Anti-PD-1 agents can breach immunologic tolerance. Fulminant diabetes is an immune endocrinopathy that results from a violent immune attack leading to complete destruction of pancreatic beta cell...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nora Chokr, Hafsa Farooq, Elizabeth Guadalupe
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	Case Reports in Oncological Medicine
Online Access:	http://dx.doi.org/10.1155/2018/8981375
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Fulminant Disseminated Intravascular Coagulation as Initial Presentation of BRAF-Mutated Melanoma
by: Jeremy Chuang, et al.
Published: (2019-01-01)

A case of eruptive keratoacanthomas and lichen planus secondary to nivolumab treatment for stage IV melanoma
by: Daniel S. Alicea, MS, et al.
Published: (2025-03-01)

Development of Fulminant Type 1 Diabetes Mellitus in a Patient with DRESS Syndrome
by: Pedro Perez, et al.
Published: (2020-01-01)

Immunological Aspects of Fulminant Type 1 Diabetes in Chinese
by: Zhen Wang, et al.
Published: (2016-01-01)

Fatal Fulminant Hepatic Failure in a Diabetic with Primary Dengue
by: Stalin Viswanathan, et al.
Published: (2010-01-01)

Association of HLA Genotype and Fulminant Type 1 Diabetes in Koreans
by: Soo Heon Kwak, et al.
Published: (2015-12-01)

Malignant Lymphoma Presenting as Fulminant Hepatic Failure
by: Elizabeth Nizalik, et al.
Published: (1989-01-01)

Severe Myositis, Myocarditis, and Myasthenia Gravis with Elevated Anti-Striated Muscle Antibody following Single Dose of Ipilimumab-Nivolumab Therapy in a Patient with Metastatic Melanoma
by: Mahdieh Fazel, et al.
Published: (2019-01-01)

Fulminant liver failure 30 year-old patient
by: Anna F. Sheptulina, et al.
Published: (2018-08-01)

An Unusual Case of Fulminant Type 1 Diabetes during the Second Trimester of Pregnancy
by: Tomohiro Okuda, et al.
Published: (2014-01-01)

Nivolumab and Ipilimumab Combination Immunotherapy for Patients with Metastatic Collecting Duct Carcinoma
by: Tetsuya Danno, et al.
Published: (2021-01-01)

A Case of Fulminant Meningococcemia: It Is All in the Complement
by: Kellie L. Hawkins, et al.
Published: (2017-01-01)

Retinal Toxicity after Initial Administration of Nivolumab and Ipilimumab
by: Adnan Kilani, et al.
Published: (2023-01-01)

Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy
by: Antonio Faieta, et al.
Published: (2021-01-01)

A Case of Nivolumab-Induced Severe Mononeuropathy Multiplex and Rhabdomyolysis
by: Katsuya Sakai, et al.
Published: (2017-01-01)

Hidradenitis suppurativa induced by ipilimumab and nivolumab: A rare association
by: Alexander D. Woods, MD, et al.
Published: (2025-03-01)

Snap diagnosis of fulminant type 1 diabetes by the normalized glucose/HbA1c ratio
by: Jun-Ichiro Mori, et al.
Published: (2024-11-01)

Early detection of myocarditis caused by immune checkpoint inhibitor therapy with nivolumab and ipilimumab for advanced recurrent renal cell carcinoma
by: Maki Todo, et al.
Published: (2025-02-01)

Pathologic Complete Response to Neoadjuvant Nivolumab/Ipilimumab in a Patient with Metastatic Renal Cell Carcinoma
by: Taylor C. Peak, et al.
Published: (2020-01-01)

Nivolumab Effective for Gastric and Lung Cancers but Not for Multiple Myeloma in a Multiple Primary Cancer Patient
by: Tsukasa Yasuda, et al.
Published: (2021-01-01)

Advances in Cell and Immune Therapies for Melanoma
by: Tanase Timis, et al.
Published: (2025-01-01)

Advances in Immunotherapy for Melanoma: A Comprehensive Review
by: Carmen Rodríguez-Cerdeira, et al.
Published: (2017-01-01)

Hepatic Encephalopathy and Cerebral Edema in Fulminant Liver Failure
by: Roger F Butterworth
Published: (1993-01-01)

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients
by: Mélanie Saint-Jean, et al.
Published: (2018-01-01)

PD-1 Blockade in Advanced Melanoma in Patients with Hepatitis C and/or HIV
by: Diwakar Davar, et al.
Published: (2015-01-01)

Acute Interstitial Nephritis in a Patient with Non-Small Cell Lung Cancer under Immunotherapy with Nivolumab
by: Panagiotis I. Georgianos, et al.
Published: (2019-01-01)

Lambert-Eaton Myasthenic Syndrome Secondary to Nivolumab and Ipilimumab in a Patient with Small-Cell Lung Cancer
by: Kavita Agrawal, et al.
Published: (2019-01-01)

Fatal Fulminant Hepatic Failure from Adenovirus in Allogeneic Bone Marrow Transplant Patients
by: Jatin M. Vyas, et al.
Published: (2012-01-01)

Extracorporeal Cardiopulmonary Resuscitation for Management of Out-of-Hospital Cardiac Arrest in a Patient with Fulminant Myocarditis
by: Alexander J. Meyer, et al.
Published: (2020-01-01)

Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
by: Benjamin Chaucer, et al.
Published: (2018-01-01)

Advances in Immunotherapy and Targeted Therapy of Malignant Melanoma
by: Xue Wang, et al.
Published: (2025-01-01)

Resolution of Crizotinib-Associated Fulminant Hepatitis following Cessation of Treatment
by: Gregory W. Charville, et al.
Published: (2018-01-01)

Fulminant Mucormycosis Involving Paranasal Sinuses: A Rare Case Report
by: Komali Garlapati, et al.
Published: (2014-01-01)

Sternectomy for Treating Advanced Non-Melanoma Skin Cancer
by: Victor Emmanuel Gadelha Pinheiro, et al.
Published: (2019-01-01)

An Autopsy Case of Fulminant Systemic Infection of Clostridium perfringens With a Diverse Role of Toxins in a Healthy Patient
by: Ayano Osamura, et al.
Published: (2024-01-01)

Extensively drug-resistant Acinetobacter baumannii lung abscess and empyema in a patient with fulminant mycoplasma pneumoniae pneumonia
by: Siyu Yang, et al.
Published: (2025-01-01)

A Case of Non-Small Cell Lung Cancer with Possible “Disease Flare” on Nivolumab Treatment
by: Shotaro Chubachi, et al.
Published: (2016-01-01)

A Rare Delayed Atypical Pseudoprogression in Nivolumab-Treated Non-Small-Cell Lung Cancer
by: Suyanto Suyanto, et al.
Published: (2019-01-01)

Fulminant Clostridium difficile Enteritis after Proctocolectomy and Ileal Pouch-Anal Anastamosis
by: Elena Boland, et al.
Published: (2008-01-01)

Familial Creutzfeldt-Jakob Disease with early onset myoclonus: A case for fulminant progression
by: Indira Naskar, et al.
Published: (2023-07-01)